Puma Biotechnology PBYI
NASDAQ PBYI
$11.26 +0.36 (+3.30%)
At close: Oct 22, 2026 · 4:00 PM EDT

Puma Biotechnology (PBYI) Change in Other Operating Liabilities (2012 - 2014)

Updated

Analysis

Puma Biotechnology (PBYI) Change in Other Operating Liabilities (2012 - 2014) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Liabilities Change (Qtr)
1 Eli Lilly 1,144.36 Bn 1,112.95 Bn 19.71 Bn -
2 Johnson & Johnson 635.36 Bn 555.22 Bn 17.30 Bn 2.69 Bn
3 AbbVie 502.79 Bn 475.90 Bn 12.70 Bn -
4 Merck 356.08 Bn 310.46 Bn 12.21 Bn -
5 Novartis Ag 300.87 Bn 264.86 Bn 11.24 Bn -
6 Astrazeneca 264.31 Bn 237.99 Bn 12.86 Bn -
7 Amgen 239.07 Bn 194.47 Bn 7.24 Bn -32.00 Mn
8 Gilead Sciences 194.50 Bn 168.70 Bn 6.22 Bn -
9 Pfizer 171.00 Bn 117.64 Bn 10.94 Bn -112.00 Mn
10 Puma Biotechnology 576.13 Mn 188.77 Mn 44.03 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2014 107,000.00
Dec 31, 2013 -7,000.00
Sep 30, 2013 -13,000.00
Jun 30, 2013 23,000.00
Mar 31, 2013 24,000.00
Dec 31, 2012 27,000.00
Sep 30, 2012 -21,000.00
Jun 30, 2012 112,000.00
Mar 31, 2012 68,000.00
API Access

Puma Biotechnology Change in Other Operating Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-other-operating-liabilities&ticker=PBYI&period=max&api_key=YOUR_API_KEY